4.5 Review

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS

Journal

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Volume 26, Issue 1, Pages 2-10

Publisher

WILEY
DOI: 10.1046/j.1365-2990.2000.00217.x

Keywords

immunohistochemistry; magnetic resonance imaging; multiple sclerosis; pathology; staging systems

Ask authors/readers for more resources

Several processes take place during an attack of demyelination in multiple sclerosis (MS). The timing of these various processes, and thus of the attack in its entirety, is important if therapeutic stratagies are to be planned. Attempts have been made to introduce and investigate variables relevant to timing the disease processes, leading to staging systems for MS. Here, the terminology and the various parameters used are reviewed, including inflammatory cells, glial cells, axonal loss and myelin staining; then the different systems are compared, including the system put forward by Bo and Trapp, our own modification of that, the Bruck and Lassmann system and the recent consensus reached at a Vienna meeting. It is concluded that an ideal staging system does not yet exist, and that, more than anything else, the material dictates the choice for a staging system. The terminology of the Vienna consensus could be used as a reference to facilitate international comparison.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available